Luban is a pharmaceutical company that develops fine chemicals and chiral products.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 22, 2017 | Post-IPO Equity | ¥37.60M | 2 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |